
01 / 04
Genuine Medicines
Tracked Shipping
Plain Packaging
Order Metadata
ReferenceGH·DAUNEON2
AvailabilityIn stock
SourceIndia
Delivery5–10 business days to your country
GH·DAUNEON2Anti-Cancer / Oncology Medicines
Dauneon 20 mg Injection
Daunorubicin is a prescription chemotherapy medicine used mainly to treat acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It works by damaging the DNA of cancer cells, which stops them from dividing and growing. It is given as an infusion into a vein by trained healthcare staff. It must be used only under the supervision of a cancer specialist.
Order This Product
Send us a message on WhatsApp with this product name — we'll come back with the price and delivery options for your country.
Description
Daunorubicin belongs to a group called anthracyclines, which slip between the strands of DNA and block an enzyme (topoisomerase II) that cancer cells need to copy themselves. It is a key drug in the treatment of AML, usually in the “7+3” regimen together with cytarabine, and is also used in ALL, often with vincristine, prednisone, and asparaginase. It is given as a slow intravenous infusion over about 30 to 60 minutes, and the dose depends on body surface area, age, and the regimen used. A liposomal combination with cytarabine (CPX-351) is also available for certain high-risk AML and is dosed differently. Its most important risk is heart damage, which depends on the total lifetime dose, so heart function is checked with an echocardiogram or similar test before and during treatment. Common side effects include nausea, vomiting, hair loss, mouth sores, tiredness, and low blood counts that raise the risk of infection and bleeding. It turns urine red or orange for a day or two, which is harmless. If the drug leaks out of the vein during infusion, it can cause severe tissue damage, so pain, burning, or swelling at the infusion site must be reported at once. Fever or signs of infection during treatment need urgent medical attention. Breathlessness, ankle swelling, or an irregular heartbeat may signal heart problems and need prompt care. The dose is reduced in people with liver or kidney problems, and it should not be used in people with severe heart disease or severe bone marrow suppression. It increases the risk of a second cancer later in life, and it can make radiation side effects worse. It can harm an unborn baby and affect fertility, so effective contraception is advised during treatment and for several months afterward, and breastfeeding should be avoided. Live vaccines should be avoided, and the doctor should know about all medicines being taken. Treatment should never be missed, changed, or stopped without the oncology team’s advice.
Specifications
- Composition
- Daunorubicin
- Strength
- 20 mg
- Treatment
- Acute Leukemia
- Packaging Type
- Vial
- Packaging Size
- 1 Vial
How this product reaches you
- 1Global Healthcare sources this product from a manufacturer in India. The manufacturer name and country are part of the order record.
- 2It is shipped from India to your address. Carrier and delivery options depend on your country and order size.
- 3Your country's import rules apply — we help you understand them on chat.
